First Covid nasal vaccine by Bharat Biotech gets regulators nod for phase 2, 3 trials
India | Aug 13, 2021, 06:49 PM ISTThe first nasal vaccine against coronavirus developed by Bharat Biotech supported by Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) has been given regulator's nod for conducting phase 2 and 3 trials, the Ministry of Science & Technology informed on Friday.